• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

西红花苷元通过抑制 Nrf2-ARE 抗氧化通路诱导顺铂耐药的头颈部癌细胞凋亡。

Hederagenin Induces Apoptosis in Cisplatin-Resistant Head and Neck Cancer Cells by Inhibiting the Nrf2-ARE Antioxidant Pathway.

机构信息

Department of Otolaryngology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.

Department of Pathology, College of Korean Medicine, Woosuk University, Jeonju-si, Jeollabuk-do, Republic of Korea.

出版信息

Oxid Med Cell Longev. 2017;2017:5498908. doi: 10.1155/2017/5498908. Epub 2017 Dec 31.

DOI:10.1155/2017/5498908
PMID:29456786
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5804377/
Abstract

Acquired resistance to cisplatin is the most common reason for the failure of cisplatin chemotherapy. Hederagenin, triterpenoids extracted from ivy leaves, exhibits antitumor activity in various types of cancer. However, the therapeutic potential of hederagenin in head and neck cancer (HNC) has remained unclear. Therefore, we examined the effects of hederagenin in cisplatin-resistant HNC cells and characterized its molecular mechanisms of action in this context. We evaluated the effects of hederagenin treatment on cell viability, apoptosis, reactive oxygen species (ROS) production, glutathione levels, mitochondrial membrane potential (Δm), and protein and mRNA expression in HNC cells. The antitumor effect of hederagenin in mouse tumor xenograft models was also analyzed. Hederagenin selectively induced cell death in both cisplatin-sensitive and cisplatin-resistant HNC cells by promoting changes in Δm and inducing apoptosis. Hederagenin inhibited the Nrf2-antioxidant response element (ARE) pathway and activated p53 in HNC cells, thereby enhancing ROS production and promoting glutathione depletion. These effects were reversed by the antioxidant trolox. Hederagenin activated intrinsic apoptotic pathways via cleaved PARP, cleaved caspase-3, and Bax. The selective inhibitory effects of hederagenin were confirmed in cisplatin-resistant HNC xenograft models. These data suggest that hederagenin induces cell death in resistant HNC cells via the Nrf2-ARE antioxidant pathway.

摘要

获得性顺铂耐药是顺铂化疗失败的最常见原因。常春藤叶中提取的三萜类化合物熊果酸具有多种类型癌症的抗肿瘤活性。然而,熊果酸在头颈部癌症(HNC)中的治疗潜力尚不清楚。因此,我们研究了熊果酸在顺铂耐药 HNC 细胞中的作用,并在该背景下对其作用机制进行了表征。我们评估了熊果酸处理对 HNC 细胞活力、细胞凋亡、活性氧(ROS)产生、谷胱甘肽水平、线粒体膜电位(Δm)以及蛋白质和 mRNA 表达的影响。还分析了熊果酸在小鼠肿瘤异种移植模型中的抗肿瘤作用。熊果酸通过改变 Δm 并诱导细胞凋亡,选择性地诱导顺铂敏感和耐药的 HNC 细胞死亡。熊果酸抑制了 HNC 细胞中的 Nrf2-抗氧化反应元件(ARE)通路并激活了 p53,从而增加了 ROS 的产生并促进了谷胱甘肽的耗竭。抗氧化剂 Trolox 可逆转这些作用。熊果酸通过裂解的 PARP、裂解的 caspase-3 和 Bax 激活内在凋亡途径。在顺铂耐药 HNC 异种移植模型中证实了熊果酸的选择性抑制作用。这些数据表明,熊果酸通过 Nrf2-ARE 抗氧化途径诱导耐药 HNC 细胞死亡。

相似文献

1
Hederagenin Induces Apoptosis in Cisplatin-Resistant Head and Neck Cancer Cells by Inhibiting the Nrf2-ARE Antioxidant Pathway.西红花苷元通过抑制 Nrf2-ARE 抗氧化通路诱导顺铂耐药的头颈部癌细胞凋亡。
Oxid Med Cell Longev. 2017;2017:5498908. doi: 10.1155/2017/5498908. Epub 2017 Dec 31.
2
Nrf2 inhibition reverses the resistance of cisplatin-resistant head and neck cancer cells to artesunate-induced ferroptosis.Nrf2抑制可逆转顺铂耐药头颈部癌细胞对青蒿琥酯诱导的铁死亡的抗性。
Redox Biol. 2017 Apr;11:254-262. doi: 10.1016/j.redox.2016.12.010. Epub 2016 Dec 18.
3
Activation of mitochondrial oxidation by PDK2 inhibition reverses cisplatin resistance in head and neck cancer.通过抑制PDK2激活线粒体氧化可逆转头颈癌中的顺铂耐药性。
Cancer Lett. 2016 Feb 1;371(1):20-9. doi: 10.1016/j.canlet.2015.11.023. Epub 2015 Nov 23.
4
Targeting Nrf2 with wogonin overcomes cisplatin resistance in head and neck cancer.汉黄芩素靶向Nrf2可克服头颈癌中的顺铂耐药性。
Apoptosis. 2016 Nov;21(11):1265-1278. doi: 10.1007/s10495-016-1284-8.
5
A Novel Polyphenol Conjugate Sensitizes Cisplatin-Resistant Head and Neck Cancer Cells to Cisplatin via Nrf2 Inhibition.一种新型多酚共轭物通过抑制Nrf2使顺铂耐药的头颈癌细胞对顺铂敏感。
Mol Cancer Ther. 2016 Nov;15(11):2620-2629. doi: 10.1158/1535-7163.MCT-16-0332. Epub 2016 Aug 22.
6
RITA plus 3-MA overcomes chemoresistance of head and neck cancer cells via dual inhibition of autophagy and antioxidant systems.RITA 联合 3-MA 通过双重抑制自噬和抗氧化系统克服头颈部癌细胞的化疗耐药性。
Redox Biol. 2017 Oct;13:219-227. doi: 10.1016/j.redox.2017.05.025. Epub 2017 Jun 1.
7
Targeting of the Glutathione, Thioredoxin, and Nrf2 Antioxidant Systems in Head and Neck Cancer.靶向治疗头颈部癌症中的谷胱甘肽、硫氧还蛋白和 Nrf2 抗氧化系统。
Antioxid Redox Signal. 2017 Jul 10;27(2):106-114. doi: 10.1089/ars.2016.6841. Epub 2016 Nov 14.
8
Nrf2 inhibition reverses resistance to GPX4 inhibitor-induced ferroptosis in head and neck cancer.Nrf2 抑制逆转了头颈部癌症对 GPX4 抑制剂诱导的铁死亡的耐药性。
Free Radic Biol Med. 2018 Dec;129:454-462. doi: 10.1016/j.freeradbiomed.2018.10.426. Epub 2018 Oct 16.
9
Induction of ferroptotic cell death for overcoming cisplatin resistance of head and neck cancer.诱导铁死亡细胞死亡以克服头颈部癌症的顺铂耐药性。
Cancer Lett. 2016 Oct 10;381(1):96-103. doi: 10.1016/j.canlet.2016.07.035. Epub 2016 Jul 28.
10
Hederagenin from the leaves of ivy (Hedera helix L.) induces apoptosis in human LoVo colon cells through the mitochondrial pathway.常春藤叶中的常春藤苷元通过线粒体途径诱导人 LoVo 结肠癌细胞凋亡。
BMC Complement Altern Med. 2014 Oct 24;14:412. doi: 10.1186/1472-6882-14-412.

引用本文的文献

1
Recent Progress in Health Benefits of Hederagenin and Its Glycosides.常春藤皂苷元及其糖苷对健康益处的最新进展
Molecules. 2025 Aug 15;30(16):3393. doi: 10.3390/molecules30163393.
2
EGCG Alleviates Lipopolysaccharide-Induced Septic Shock by Inhibiting NET-Mediated ROS Production by Regulating CXCL2 Expression.表没食子儿茶素没食子酸酯通过调节CXCL2表达抑制中性粒细胞胞外诱捕网介导的活性氧生成来减轻脂多糖诱导的脓毒症休克。
Biochem Genet. 2025 Jul 16. doi: 10.1007/s10528-025-11198-w.
3
Ivy Leaf Dry Extract EA 575 Is a Potent Immunomodulator Acting on Dendritic Cells.

本文引用的文献

1
Hederagenin Supplementation Alleviates the Pro-Inflammatory and Apoptotic Response to Alcohol in Rats.补充常春藤皂苷元可减轻大鼠对酒精的促炎和凋亡反应。
Nutrients. 2017 Jan 6;9(1):41. doi: 10.3390/nu9010041.
2
Hederagenin and α-hederin promote degradation of proteins in neurodegenerative diseases and improve motor deficits in MPTP-mice.常春藤皂苷元与α-常春藤皂苷可促进神经退行性疾病中蛋白质的降解,并改善MPTP诱导的小鼠运动功能障碍。
Pharmacol Res. 2017 Jan;115:25-44. doi: 10.1016/j.phrs.2016.11.002. Epub 2016 Nov 9.
3
Targeting Nrf2 with wogonin overcomes cisplatin resistance in head and neck cancer.
常春藤叶干提取物EA 575是一种作用于树突状细胞的强效免疫调节剂。
Pharmaceutics. 2025 Jun 12;17(6):773. doi: 10.3390/pharmaceutics17060773.
4
Current Progress of Hederagenin and Its Derivatives for Disease Therapy (2017-Present).常春藤皂苷元及其衍生物用于疾病治疗的研究进展(2017年至今)
Molecules. 2025 Mar 12;30(6):1275. doi: 10.3390/molecules30061275.
5
Elucidating the Molecular Mechanisms of Hederagenin-Regulated Mitophagy in Cervical Cancer SiHa Cells through an Integrative Approach Combining Proteomics and Advanced Network Association Algorithm.通过蛋白质组学与先进网络关联算法相结合的综合方法阐明常春藤皂苷元调控宫颈癌SiHa细胞线粒体自噬的分子机制
J Proteome Res. 2025 Apr 4;24(4):2081-2095. doi: 10.1021/acs.jproteome.5c00022. Epub 2025 Mar 26.
6
Exploring the therapeutic potential of oleanolic acid and its derivatives in cancer treatment: a comprehensive review.探索齐墩果酸及其衍生物在癌症治疗中的治疗潜力:一项综合综述。
3 Biotech. 2025 Mar;15(3):56. doi: 10.1007/s13205-025-04209-5. Epub 2025 Feb 7.
7
Strategies to Overcome Intrinsic and Acquired Resistance to Chemoradiotherapy in Head and Neck Cancer.克服头颈癌对放化疗的内在和获得性耐药的策略
Cells. 2024 Dec 27;14(1):18. doi: 10.3390/cells14010018.
8
Hederagenin regulates the migration and invasion of hepatocellular carcinoma cells through FOXO signaling pathway.当亲代 DNA 受到损伤或细胞周期调控出现异常时,细胞会进入细胞周期阻滞,从而避免基因组不稳定和恶性转化。
PLoS One. 2024 Oct 9;19(10):e0310930. doi: 10.1371/journal.pone.0310930. eCollection 2024.
9
Natural products for enhancing the sensitivity or decreasing the adverse effects of anticancer drugs through regulating the redox balance.通过调节氧化还原平衡来增强抗癌药物敏感性或降低其不良反应的天然产物。
Chin Med. 2024 Aug 20;19(1):110. doi: 10.1186/s13020-024-00982-2.
10
Research Progress on the Anti-Cancer Effects of Saponins and Their Mechanisms of Action.皂苷的抗肿瘤作用及其作用机制的研究进展。
Molecules. 2024 Jul 18;29(14):3388. doi: 10.3390/molecules29143388.
汉黄芩素靶向Nrf2可克服头颈癌中的顺铂耐药性。
Apoptosis. 2016 Nov;21(11):1265-1278. doi: 10.1007/s10495-016-1284-8.
4
Follow-up in Head and Neck Cancer: Do More Does It Mean Do Better? A Systematic Review and Our Proposal Based on Our Experience.头颈癌的随访:做得更多就意味着做得更好吗?一项系统综述及基于我们经验的建议
Clin Exp Otorhinolaryngol. 2016 Dec;9(4):287-297. doi: 10.21053/ceo.2015.00976. Epub 2016 Jun 25.
5
Trends in Head and Neck Cancer in South Korea Between 1999 and 2012.1999年至2012年韩国头颈癌的发病趋势
Clin Exp Otorhinolaryngol. 2016 Sep;9(3):263-9. doi: 10.21053/ceo.2015.01123. Epub 2016 May 3.
6
Cytoplasmic localization of Nrf2 promotes colorectal cancer with more aggressive tumors via upregulation of PSMD4.Nrf2的细胞质定位通过上调PSMD4促进具有更具侵袭性肿瘤的结直肠癌。
Free Radic Biol Med. 2016 Jun;95:121-32. doi: 10.1016/j.freeradbiomed.2016.03.014. Epub 2016 Mar 23.
7
Tumor Regression Patterns Based on Follow-up Duration in Patients With Head and Neck Squamous Cell Carcinoma Treated With Radiotherapy or Chemoradiotherapy.基于放疗或放化疗的头颈部鳞状细胞癌患者随访时间的肿瘤消退模式
Clin Exp Otorhinolaryngol. 2015 Dec;8(4):416-21. doi: 10.3342/ceo.2015.8.4.416. Epub 2015 Nov 10.
8
Hederagenin as a triterpene template for the development of new antitumor compounds.齐墩果酸作为开发新型抗肿瘤化合物的三萜模板。
Eur J Med Chem. 2015 Nov 13;105:57-62. doi: 10.1016/j.ejmech.2015.10.006. Epub 2015 Oct 9.
9
Bioassay Guided Fractionation Identified Hederagenin as a Major Cytotoxic Agent from Cyclocarya paliurus Leaves.生物测定导向的分级分离鉴定出齐墩果酸是青钱柳树叶中的主要细胞毒性剂。
Planta Med. 2016 Jan;82(1-2):171-9. doi: 10.1055/s-0035-1557900. Epub 2015 Sep 21.
10
Global cancer statistics, 2012.全球癌症统计数据,2012 年。
CA Cancer J Clin. 2015 Mar;65(2):87-108. doi: 10.3322/caac.21262. Epub 2015 Feb 4.